For research use only. Not for therapeutic Use.
(R)-Irsenontrine（Cat No.:I042765）is an investigational compound being studied for its potential therapeutic effects, particularly in the field of oncology. It is an enantiomer of Irsenontrine, which acts as an inhibitor of specific enzymes involved in cancer cell proliferation and survival. The (R)-isomer is thought to have enhanced potency and selectivity in targeting these pathways. By modulating cell signaling and inducing cell cycle arrest or apoptosis in tumor cells, (R)-Irsenontrine may offer a novel approach for treating various cancers, including those resistant to conventional therapies. Currently, it is undergoing preclinical and clinical evaluations.
| CAS Number | 1429509-81-8 |
| Synonyms | 7-(2-methoxy-3,5-dimethylpyridin-4-yl)-1-[(3R)-oxolan-3-yl]-5H-pyrazolo[4,3-c]quinolin-4-one |
| Molecular Formula | C22H22N4O3 |
| Purity | ≥95% |
| IUPAC Name | 7-(2-methoxy-3,5-dimethylpyridin-4-yl)-1-[(3R)-oxolan-3-yl]-5H-pyrazolo[4,3-c]quinolin-4-one |
| InChI | InChI=1S/C22H22N4O3/c1-12-9-23-22(28-3)13(2)19(12)14-4-5-16-18(8-14)25-21(27)17-10-24-26(20(16)17)15-6-7-29-11-15/h4-5,8-10,15H,6-7,11H2,1-3H3,(H,25,27)/t15-/m1/s1 |
| InChIKey | CKJDCNZBABIEBZ-OAHLLOKOSA-N |
| SMILES | CC1=CN=C(C(=C1C2=CC3=C(C=C2)C4=C(C=NN4[C@@H]5CCOC5)C(=O)N3)C)OC |
